These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16898058)

  • 21. Quality assessments by sick and healthy beneficiaries in traditional Medicare and Medicare managed care.
    Keenan PS; Elliott MN; Cleary PD; Zaslavsky AM; Landon BE
    Med Care; 2009 Aug; 47(8):882-8. PubMed ID: 19543123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do HMOs reduce preventable hospitalizations for Medicare beneficiaries?
    Basu J; Mobley LR
    Med Care Res Rev; 2007 Oct; 64(5):544-67. PubMed ID: 17881621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient activation status as a predictor of patient experience among Medicare beneficiaries.
    Heller A; Elliott MN; Haviland AM; Klein DJ; Kanouse DE
    Med Care; 2009 Aug; 47(8):850-7. PubMed ID: 19584763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare spending on HMOs and stand-alone drug plans: what is it worth to beneficiaries?
    Austin BJ
    Find Brief; 2008 Nov; 11(8):1-3. PubMed ID: 19035029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicare Advantage in 2006-2007: what Congress intended?
    Gold M
    Health Aff (Millwood); 2007; 26(4):w445-55. PubMed ID: 17504767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Part D implementation: how did health plans fare? A conversation with Stan Nowak, founder, president, and chief executive officer of Silverlink Communications. Interview by William Atkinson.
    Nowak S
    AHIP Cover; 2006; 47(4):46, 49, 51. PubMed ID: 16894854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paying Medicare Advantage plans by competitive bidding: how much competition is there?
    Biles B; Pozen J; Guterman S
    Issue Brief (Commonw Fund); 2009 Aug; 65():1-12. PubMed ID: 19685587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Special Needs Plans and the coordination of benefits and services for dual eligibles.
    Grabowski DC
    Health Aff (Millwood); 2009; 28(1):136-46. PubMed ID: 19124863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State Medicaid managed care enrollment: understanding the political calculus that drives Medicaid managed care reforms.
    Pracht EE
    J Health Polit Policy Law; 2007 Aug; 32(4):685-731. PubMed ID: 17639017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managed Medicare may help seniors avoid preventable hospitalizations through better coordination of care.
    Capitation Rates Data; 2008 Jul; 13(7):11-2. PubMed ID: 18649796
    [No Abstract]   [Full Text] [Related]  

  • 32. The cost of privatization: extra payments to Medicare Advantage plans--updated and revised.
    Biles B; Hersch Nicholas L; Cooper BS; Adrion E; Guterman S
    Issue Brief (Commonw Fund); 2006 Nov; 23():1-16. PubMed ID: 17153271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pursuing cost containment in a pluralistic payer environment: from the aftermath of Clinton's failure at health care reform to the Balanced Budget Act of 1997.
    Mayes R; Hurley RE
    Health Econ Policy Law; 2006 Jul; 1(Pt 3):237-61. PubMed ID: 18634695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for improving health plan member retention.
    Wood SD
    Healthc Financ Manage; 1999; Suppl():1-5. PubMed ID: 10338934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The continuing cost of privatization: extra payments to Medicare Advantage plans jump to $11.4 billion in 2009.
    Biles B; Pozen J; Guterman S
    Issue Brief (Commonw Fund); 2009 May; 51():1-18. PubMed ID: 19449498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
    De Natale ML
    Policy Polit Nurs Pract; 2007 Aug; 8(3):170-81. PubMed ID: 18178923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicare HMO impact on utilization at the end of life.
    Fonkych K; O'Leary JF; Melnick GA; Keeler EB
    Am J Manag Care; 2008 Aug; 14(8):505-12. PubMed ID: 18690766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of branding in health care.
    Acton V
    Manag Care Q; 1998; 6(4):15-9. PubMed ID: 10185773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
    Polinski JM; Mohr PE; Johnson L
    Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in Medicaid managed care. Serving members with special needs.
    Healthplan; 2000; 41(5):70-1. PubMed ID: 11142262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.